Neurontin

In the mid-1990s, the FDA approved the sale of Neurontin for treating epilepsy. However, it is estimated that nearly 80% of users turned to the drug not to curb seizures but to treat other conditions for which it is NOT approved, including: bipolar disorder, neuropathy, attention deficit disorder (ADD), restless leg syndrome, migraines, neuralgia, and drug and alcohol withdrawal seizures. Its maker, formerly Parke-Davis but now a division of pharmaceutical giant Pfizer, is believed to have marketed the drug for these unapproved uses. Unfortunately, this is not only illegal, but extremely dangerous. Neurontin causes suicidal thoughts, suicidal ideation, anxiety, hostility, paranoia and psychosis.

 

The drug and Pfizer’s allegedly illegal activity are currently under investigation. For more information about Neurontin or if you or a loved one has been harmed by this drug, please contact us.

 

Request To FDA To Investigate

FDA Response

Plea Objection

Reply to FDA Response

 

Recent Articles:

 

March 21, 2010 The Washington Post When Drug Makers' Profits Outweigh Penalties.

Pfizer Told to Pay $142.1 Million for Neurontin Marketing Fraud.

Article in JAMA April 14, 2010: Anticonvulsant Medications and the Risk of Suicide, Attempted Suicide

or Violent Death.